Article

Seattle TimesSeattle Times on 2024-04-30 19:04

US challenges ‘bogus’ patents on Ozempic and other drugs in effort to spur competition

The Federal Trade Commission is challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic.

Related news